Mar 06, 2023 / 06:30PM GMT
Unidentified Analyst -
At the Cowen conference again this year. Representing the company is Mike Mason, who is President of Lilly Diabetes. So Mike, thank you for making the journey. Lots to cover, obviously, an incredibly exciting business within Lilly. And so let's start right out.
Questions and Answers:
Unidentified Analyst -We're all kind of fixated on the obesity opportunity -- and just how big it could be. What are the biggest challenges and barriers to growing obesity treatment in this country and outside the country?
Michael B. Mason - Eli Lilly and Company - Senior VP & President of Lilly Diabetes
All right. Well, thanks for the question. Good to see everyone. We're all packed into a tight room, hopefully, no one has COVID or we'll all have it. But, yes, I know everyone here is excited about obesity and trying to figure out the size of it. Obviously, we're doing the same thing at Lilly and trying to make it as massive an opportunity to help as many patients as possible. It is a chronic disease that really affects
Trustpilot
